Strong improvement of apolipoprotein e/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 9, 2014, Pages 2240-2249

  Yamashita, Toru ^a   Zhai, Yun ^a   Kurata, Tomoko ^a   Hishikawa, Nozomi ^a   Morimoto, Nobutoshi ^a   Ohta, Yasuyuki ^a   Deguchi, Kentaro ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; ApoE LDL R; rat; spontaneously hypertensive; telmisartan

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN 2; TELMISARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BRAIN CORTEX; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOLIPOPROTEINS E; BENZIMIDAZOLES; BENZOATES; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; RATS; RATS, INBRED SHR; RECEPTORS, LDL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STROKE;

EID: 84907978654     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2014.04.010     Document Type: Article

References (26)

1. D.J. Selkoe Toward a remembrance of things past: deciphering Alzheimer disease Harvey Lect 99 2003 23 45
2. M. Mogi, and M. Horiuchi Neurovascular coupling in cognitive impairment associated with diabetes mellitus Circ J 75 2011 1042 1048
3. I. Skoog, and D. Gustafson Update on hypertension and Alzheimer's disease Neurol Res 28 2006 605 611
4. L.H. Kuller, O.L. Lopez, and W.J. Jagust Determinants of vascular dementia in the Cardiovascular Health Cognition Study Neurology 64 2005 1548 1552
5. K.M. Hayden, P.P. Zandi, and C.G. Lyketsos Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study Alzheimer Dis Assoc Disord 20 2006 93 100
6. R.W. Alexander Leukocyte and endothelial angiotensin II type 1 receptors and microvascular thrombotic and inflammatory responses to hypercholesterolemia Arterioscler Thromb Vasc Biol 26 2006 240 241
7. D. Carnevale, G. Mascio, and I. D'Andrea Hypertension induces brain beta-Amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature Hypertension 60 2012 188 197
8. A.S. Watts, N. Loskutova, and J.M. Burns Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults J Alzheimers Dis 35 2013 253 265
9. M.P. Burns, W.J. Noble, and V. Olm Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques Brain Res Mol Brain Res 110 2003 119 125
10. Q. Jiang, C.Y. Lee, and S. Mandrekar ApoE promotes the proteolytic degradation of Abeta Neuron 58 2008 681 693
11. M. Koistinaho, S. Lin, and X. Wu Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides Nat Med 10 2004 719 726
12. Z. Guo, L. Fratiglioni, and L. Zhu Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use Arch Neurol 56 1999 991 996
13. M.D. Murray, K.A. Lane, and S. Gao Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans Arch Intern Med 162 2002 2090 2096
14. P. Gohlke, S. Weiss, and A. Jansen AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats J Pharmacol Exp Ther 298 2001 62 70
15. M.P. Maillard, C. Perregaux, and C. Centeno In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist J Pharmacol Exp Ther 302 2002 1089 1095
16. M. Sabbatini, A. Catalani, and C. Consoli The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia? Mech Ageing Dev 123 2002 547 559
17. M. Pravenec, V. Landa, and V. Zidek Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension Physiol Res 52 2003 681 688
18. D. Sanz-Rosa, M.P. Oubina, and E. Cediel Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences Antioxid Redox Signal 7 2005 1294 1301
19. M. Korenova, N. Zilka, and Z. Stozicka NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy J Neurosci Methods 177 2009 108 114
20. T. Kurata, V. Lukic, and M. Kozuki Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR after tMCAO Transl Stroke Res 2014
21. A.H. Khan, and J.D. Imig Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome Am J Hypertens 24 2011 816 821
22. K. Tsukuda, M. Mogi, and J. Iwanami Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-Activated receptor-gamma activation Hypertension 54 2009 782 787
23. J.C. Dodart, R.A. Marr, and M. Koistinaho Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease Proc Natl Acad Sci U S A 102 2005 1211 1216
24. W.J. Brecht, F.M. Harris, and S. Chang Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice J Neurosci 24 2004 2527 2534
25. J. Brodeur, C. Theriault, and M. Lessard-Beaudoin LDLR-related protein 10 (LRP10) regulates amyloid precursor protein (APP) trafficking and processing: evidence for a role in Alzheimer's disease Mol Neurodegener 7 2013 31
26. H. Kamada, T. Hayashi, and K. Sato Up-regulation of low-density lipoprotein receptor expression in the ischemic core and the peri-ischemic area after transient MCA occlusion in rats Brain Res Mol Brain Res 134 2005 181 188